Laura Mateu1,2, Laura Izquierdo3, Agustín Franco3, Meritxell Costa3, Nathan Lawrentschuk4, Antonio Alcaraz3. 1. Department and Laboratory of Urology of Hospital Clinic, Barcelona, Spain. lmateuarrom@hotmail.com. 2. Department of Urology of Hospital Plató, Barcelona, Spain. lmateuarrom@hotmail.com. 3. Department and Laboratory of Urology of Hospital Clinic, Barcelona, Spain. 4. Department of Surgery, University of Melbourne, Austin Hospital, Melbourne, Australia.
Abstract
INTRODUCTION AND HYPOTHESIS: Bladder pain syndrome (BPS) is a chronic condition with severe implications in the patient's quality of life with no definitive treatment. Our objective was to assess pain relief after triamcinolone injection in patients with BPS with Hunner's ulcers (HU). METHODS: Retrospective study of 20 consecutive patients with BPS treated at the Hospital Clinic of Barcelona with triamcinolone injection with flexible cystoscope between 2015 and 2016. Pain was assessed according to the visual analog scale (VAS) (0-10) before and after treatment. Outcomes were compared using Student's t test for paired samples. RESULTS: Twenty-seven procedures were performed in 20 patients, who were followed up for a median of 7 months (range 1-15). Median age was 75 years (52-86), and median time from diagnosis to treatment was 4.5 years (1-7). Fifteen (75 %) patients had received treatment with corticoid injection for BPS before entering the study. Pre- and postreatment VAS was 8 and 2.5 (p < 0.001), respectively. Pre -and postreatment VAS in those with muscular pain was 8 and 5 (p = 0.012), respectively and in those without muscular pain was 8 and 2 (p < 0.001), respectively. Three (15 %) patients required retreatment due to nonresponse and 5 (25 %) patients for pain recurrence after 4 months (3.5-8). Four of them (50 %) were performed with triamcinolone injection again. Seven of ten patients (70 %) followed for ≥8 months required at least one retreatment. CONCLUSION: Triamcinolone injection for HU in patients with BPS is associated with significant pain reduction. However, most patients will require retreatment.
INTRODUCTION AND HYPOTHESIS: Bladder pain syndrome (BPS) is a chronic condition with severe implications in the patient's quality of life with no definitive treatment. Our objective was to assess pain relief after triamcinolone injection in patients with BPS with Hunner's ulcers (HU). METHODS: Retrospective study of 20 consecutive patients with BPS treated at the Hospital Clinic of Barcelona with triamcinolone injection with flexible cystoscope between 2015 and 2016. Pain was assessed according to the visual analog scale (VAS) (0-10) before and after treatment. Outcomes were compared using Student's t test for paired samples. RESULTS: Twenty-seven procedures were performed in 20 patients, who were followed up for a median of 7 months (range 1-15). Median age was 75 years (52-86), and median time from diagnosis to treatment was 4.5 years (1-7). Fifteen (75 %) patients had received treatment with corticoid injection for BPS before entering the study. Pre- and postreatment VAS was 8 and 2.5 (p < 0.001), respectively. Pre -and postreatment VAS in those with muscular pain was 8 and 5 (p = 0.012), respectively and in those without muscular pain was 8 and 2 (p < 0.001), respectively. Three (15 %) patients required retreatment due to nonresponse and 5 (25 %) patients for pain recurrence after 4 months (3.5-8). Four of them (50 %) were performed with triamcinolone injection again. Seven of ten patients (70 %) followed for ≥8 months required at least one retreatment. CONCLUSION:Triamcinolone injection for HU in patients with BPS is associated with significant pain reduction. However, most patients will require retreatment.
Authors: Christian Temml; Clemens Wehrberger; Claus Riedl; Anton Ponholzer; Martin Marszalek; Stephan Madersbacher Journal: Eur Urol Date: 2006-08-30 Impact factor: 20.096
Authors: Avinash Chennamsetty; Iyad Khourdaji; Jonathan Goike; Kim A Killinger; Benjamin Girdler; Kenneth M Peters Journal: Urology Date: 2014-11-05 Impact factor: 2.649
Authors: Kenneth M Peters; Donna J Carrico; Scott E Kalinowski; Ibrahim A Ibrahim; Ananias C Diokno Journal: Urology Date: 2007-07 Impact factor: 2.649
Authors: Joel H Hillelsohn; Soroush Rais-Bahrami; Justin I Friedlander; Zhamshid Okhunov; Mahyar Kashan; Lisa Rosen; Robert M Moldwin Journal: J Urol Date: 2012-10-22 Impact factor: 7.450
Authors: M Fall; A P Baranowski; C J Fowler; V Lepinard; J G Malone-Lee; E J Messelink; F Oberpenning; J L Osborne; S Schumacher Journal: Eur Urol Date: 2004-12 Impact factor: 20.096